Fragile Fracture Care Management Program

Tweet

Maggie Che, MD; Bruce Ettinger, MD; Jennifer Johnston, MPH; Alice Pressman, MS; Judy Liang, PharmD

Winter 2005 - Volume 9 Number 1

https://doi.org/10.7812/TPP/04-118

Introduction

Previous osteoporotic fracture is a strong risk factor for recurrent fracture, both in men and in women,1-7 yet only one in five patients receive osteoporosis intervention after sustaining a fracture.8 In 2003, implementation of a new HEDIS measure assessing health plan performance on postfracture care reflected national recognition of the importance and magnitude of this issue. The HEDIS measure assesses the percentage of women 67 years of age and older who receive either a bone mineral density (BMD) test or a prescription for an osteoporosis drug within six months after sustaining a fracture.